These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
355 related articles for article (PubMed ID: 30513115)
1. The molecular connection of histopathological heterogeneity in hepatocellular carcinoma: A role of Wnt and Hedgehog signaling pathways. Tripathy A; Thakurela S; Sahu MK; Uthanasingh K; Behera M; Ajay AK; Kumari R PLoS One; 2018; 13(12):e0208194. PubMed ID: 30513115 [TBL] [Abstract][Full Text] [Related]
2. Implication of the Hedgehog pathway in hepatocellular carcinoma. Della Corte CM; Viscardi G; Papaccio F; Esposito G; Martini G; Ciardiello D; Martinelli E; Ciardiello F; Morgillo F World J Gastroenterol; 2017 Jun; 23(24):4330-4340. PubMed ID: 28706416 [TBL] [Abstract][Full Text] [Related]
3. Stearoyl-CoA Desaturase Promotes Liver Fibrosis and Tumor Development in Mice via a Wnt Positive-Signaling Loop by Stabilization of Low-Density Lipoprotein-Receptor-Related Proteins 5 and 6. Lai KKY; Kweon SM; Chi F; Hwang E; Kabe Y; Higashiyama R; Qin L; Yan R; Wu RP; Lai K; Fujii N; French S; Xu J; Wang JY; Murali R; Mishra L; Lee JS; Ntambi JM; Tsukamoto H Gastroenterology; 2017 May; 152(6):1477-1491. PubMed ID: 28143772 [TBL] [Abstract][Full Text] [Related]
4. Role of Hedgehog signaling pathway in proliferation and invasiveness of hepatocellular carcinoma cells. Cheng WT; Xu K; Tian DY; Zhang ZG; Liu LJ; Chen Y Int J Oncol; 2009 Mar; 34(3):829-36. PubMed ID: 19212688 [TBL] [Abstract][Full Text] [Related]
5. Role of insulin receptor substrates in the progression of hepatocellular carcinoma. Sakurai Y; Kubota N; Takamoto I; Obata A; Iwamoto M; Hayashi T; Aihara M; Kubota T; Nishihara H; Kadowaki T Sci Rep; 2017 Jul; 7(1):5387. PubMed ID: 28710407 [TBL] [Abstract][Full Text] [Related]
6. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation. Abitbol S; Dahmani R; Coulouarn C; Ragazzon B; Mlecnik B; Senni N; Savall M; Bossard P; Sohier P; Drouet V; Tournier E; Dumont F; Sanson R; Calderaro J; Zucman-Rossi J; Vasseur-Cognet M; Just PA; Terris B; Perret C; Gilgenkrantz H J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529 [TBL] [Abstract][Full Text] [Related]
7. Down-regulated FSTL5 promotes cell proliferation and survival by affecting Wnt/β-catenin signaling in hepatocellular carcinoma. Zhang D; Ma X; Sun W; Cui P; Lu Z Int J Clin Exp Pathol; 2015; 8(3):3386-94. PubMed ID: 26045876 [TBL] [Abstract][Full Text] [Related]
8. The microtubule-associated protein PRC1 promotes early recurrence of hepatocellular carcinoma in association with the Wnt/β-catenin signalling pathway. Chen J; Rajasekaran M; Xia H; Zhang X; Kong SN; Sekar K; Seshachalam VP; Deivasigamani A; Goh BK; Ooi LL; Hong W; Hui KM Gut; 2016 Sep; 65(9):1522-34. PubMed ID: 26941395 [TBL] [Abstract][Full Text] [Related]
9. Wnt/beta-catenin signaling pathway in hepatocellular carcinomas cases from Colombia. Suarez M I; Uribe D; Jaramillo CM; Osorio G; Perez JC; Lopez R; Hoyos S; Hainaut P; Pineau P; Navas MC Ann Hepatol; 2015; 14(1):64-74. PubMed ID: 25536643 [TBL] [Abstract][Full Text] [Related]
10. Complete response of Ctnnb1-mutated tumours to β-catenin suppression by locked nucleic acid antisense in a mouse hepatocarcinogenesis model. Delgado E; Okabe H; Preziosi M; Russell JO; Alvarado TF; Oertel M; Nejak-Bowen KN; Zhang Y; Monga SP J Hepatol; 2015 Feb; 62(2):380-7. PubMed ID: 25457204 [TBL] [Abstract][Full Text] [Related]
11. Saxagliptin defers thioacetamide-induced hepatocarcinogenesis in rats: A novel suppressive impact on Wnt/Hedgehog/Notch1 signaling. Abd Elhameed AG; Helal MG; Said E; Salem HA Environ Toxicol Pharmacol; 2021 Aug; 86():103668. PubMed ID: 33945853 [TBL] [Abstract][Full Text] [Related]
12. Upregulation of musashi1 increases malignancy of hepatocellular carcinoma via the Wnt/β-catenin signaling pathway and predicts a poor prognosis. Liu Q; Zhou C; Zhang B BMC Gastroenterol; 2019 Dec; 19(1):230. PubMed ID: 31888604 [TBL] [Abstract][Full Text] [Related]
13. Silybum marianum total extract, silymarin and silibinin abate hepatocarcinogenesis and hepatocellular carcinoma growth via modulation of the HGF/c-Met, Wnt/β-catenin, and PI3K/Akt/mTOR signaling pathways. Yassin NYS; AbouZid SF; El-Kalaawy AM; Ali TM; Almehmadi MM; Ahmed OM Biomed Pharmacother; 2022 Jan; 145():112409. PubMed ID: 34781148 [TBL] [Abstract][Full Text] [Related]
14. MiR-342 regulates cell proliferation and apoptosis in hepatocellular carcinoma through Wnt/β-catenin signaling pathway. Lu C; Jia S; Zhao S; Shao X Cancer Biomark; 2019; 25(1):115-126. PubMed ID: 31006667 [TBL] [Abstract][Full Text] [Related]
15. Rspo2-LGR4 exacerbates hepatocellular carcinoma progression via activation of Wnt/β-catenin signaling pathway. Bi Y; Zhang L; Song Y; Sun L; Mulholland MW; Yin Y; Zhang W Gastroenterol Hepatol; 2024 Apr; 47(4):352-365. PubMed ID: 37437654 [TBL] [Abstract][Full Text] [Related]
16. Targeting Wnt/β-catenin pathway in hepatocellular carcinoma treatment. Vilchez V; Turcios L; Marti F; Gedaly R World J Gastroenterol; 2016 Jan; 22(2):823-32. PubMed ID: 26811628 [TBL] [Abstract][Full Text] [Related]
17. A double-negative feedback loop between Wnt-β-catenin signaling and HNF4α regulates epithelial-mesenchymal transition in hepatocellular carcinoma. Yang M; Li SN; Anjum KM; Gui LX; Zhu SS; Liu J; Chen JK; Liu QF; Ye GD; Wang WJ; Wu JF; Cai WY; Sun GB; Liu YJ; Liu RF; Zhang ZM; Li BA J Cell Sci; 2013 Dec; 126(Pt 24):5692-703. PubMed ID: 24101726 [TBL] [Abstract][Full Text] [Related]
18. Resveratrol interferes with N-nitrosodiethylamine-induced hepatocellular carcinoma at early and advanced stages in male Wistar rats. Rajasekaran D; Elavarasan J; Sivalingam M; Ganapathy E; Kumar A; Kalpana K; Sakthisekaran D Mol Med Rep; 2011; 4(6):1211-7. PubMed ID: 21850372 [TBL] [Abstract][Full Text] [Related]
20. Oncogenic STRAP Supports Hepatocellular Carcinoma Growth by Enhancing Wnt/β-Catenin Signaling. Wang W; Li S; Liu P; Sideras K; van de Werken HJG; van der Heide M; Cao W; Lavrijsen M; Peppelenbosch MP; Bruno M; Pan Q; Smits R Mol Cancer Res; 2019 Feb; 17(2):521-531. PubMed ID: 30257989 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]